Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.6%

30 terminated/withdrawn out of 206 trials

Success Rate

77.3%

-9.2% vs industry average

Late-Stage Pipeline

24%

49 trials in Phase 3/4

Results Transparency

14%

14 of 102 completed trials have results

Key Signals

36 recruiting14 with results23 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

102(59.0%)

Phase 4

26(15.0%)

Phase 3

23(13.3%)

Phase 2

15(8.7%)

Phase 1

6(3.5%)

Early Phase 1

1(0.6%)

173Total

N/A(102)

Phase 4(26)

Phase 3(23)

Phase 2(15)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (206)

Showing 20 of 206 trials

NCT06091319Recruiting

Florbetaben for Imaging of Vascular Amyloid

Role: lead

NCT05825898Enrolling By Invitation

Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

Role: lead

NCT05632601Not ApplicableActive Not Recruiting

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

Role: lead

NCT03103932Not ApplicableRecruiting

Biomarker Guided Discharge of Heart Failure Patients

Role: lead

NCT05298124Not ApplicableRecruiting

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

Role: lead

NCT05085860Not ApplicableRecruiting

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation

Role: lead

NCT03938116Not ApplicableCompleted

Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health Outcomes

Role: lead

NCT06547788Not ApplicableNot Yet Recruiting

LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY

Role: lead

NCT03331484Phase 3Completed

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention

Role: lead

NCT05253794Phase 2Completed

Effect of Colchicine on the Progression of Aortic Valve Stenosis - A Pilot Study

Role: lead

NCT04163081Not ApplicableRecruiting

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments

Role: lead

NCT03729401Phase 4Terminated

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

Role: lead

NCT03649204Completed

Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD

Role: lead

NCT02347722Active Not Recruiting

Biomarkers to Classify Heart Failure

Role: lead

NCT02184013Not ApplicableActive Not Recruiting

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Role: lead

NCT05427084Phase 2Recruiting

Canagliflozin Targeting Vascular Inflammation

Role: lead

NCT02840201Completed

Sub-Clinical Atrial Fibrillation Biomarker Study

Role: lead

NCT03344159Phase 4Completed

Spironolactone Therapy in Chronic Stable Right HF Trial

Role: lead

NCT06710080Phase 3Recruiting

Targeting Vascular INflammation in Patients With Community-Acquired Pneumonia

Role: lead

NCT01993537Phase 4Completed

The Role of Vitamin D in the Pathophysiology of Chronic Failure

Role: lead